These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3510146)

  • 1. Azathioprine and hepatic venocclusive disease in renal transplant patients.
    Katzka DA; Saul SH; Jorkasky D; Sigal H; Reynolds JC; Soloway RD
    Gastroenterology; 1986 Feb; 90(2):446-54. PubMed ID: 3510146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Favourable outcome of hepatic veno-occlusive disease in a renal transplant patient receiving azathioprine, treated by portacaval shunt. Report of a case and review of the literature.
    Eisenhauer T; Hartmann H; Rumpf KW; Helmchen U; Scheler F; Creutzfeldt W
    Digestion; 1984; 30(3):185-90. PubMed ID: 6389237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic vascular disease after kidney transplantation: report of two cases and review of the literature.
    Adler M; Delhaye M; Deprez C; Hardy N; Gelin M; De Pauw L; Vereerstraeten P; Cremer M; Toussaint C
    Nephrol Dial Transplant; 1987; 2(3):183-8. PubMed ID: 3114679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic sinusoidal dilatation with portal hypertension during azathioprine treatment after kidney transplantation.
    Gerlag PG; Lobatto S; Driessen WM; Deckers PF; Van Hooff JP; Schröder E; Assmann KM; Van Haelst UJ
    J Hepatol; 1985; 1(4):339-48. PubMed ID: 3902952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic veno-occlusive disease associated with renal transplantation and azathioprine therapy.
    Read AE; Wiesner RH; LaBrecque DR; Tifft JG; Mullen KD; Sheer RL; Petrelli M; Ricanati ES; McCullough AJ
    Ann Intern Med; 1986 May; 104(5):651-5. PubMed ID: 3008617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic veno-occlusive disease in a renal transplant patient receiving azathioprine.
    Marubbio AT; Danielson B
    Gastroenterology; 1975 Sep; 69(3):739-43. PubMed ID: 1098955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An analysis of hepatic venocclusive disease and centrilobular hepatic degeneration following bone marrow transplantation.
    Shulman HM; McDonald GB; Matthews D; Doney KC; Kopecky KJ; Gauvreau JM; Thomas ED
    Gastroenterology; 1980 Dec; 79(6):1178-91. PubMed ID: 7002704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver disease in kidney transplant patients receiving azathioprine.
    Ireland P; Rashid A; von Lichtenberg F; Cavallo T; Merrill JP
    Arch Intern Med; 1973 Jul; 132(1):29-37. PubMed ID: 4577390
    [No Abstract]   [Full Text] [Related]  

  • 9. Doppler sonography: a noninvasive method for evaluation of hepatic venocclusive disease.
    Brown BP; Abu-Yousef M; Farner R; LaBrecque D; Gingrich R
    AJR Am J Roentgenol; 1990 Apr; 154(4):721-4. PubMed ID: 2107664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic sinusoidal dilatation with portal hypertension during azathioprine treatment: a cause of chronic liver disease after kidney transplantation.
    Gerlag PG; van Hooff JP
    Transplant Proc; 1987 Oct; 19(5):3699-703. PubMed ID: 3313895
    [No Abstract]   [Full Text] [Related]  

  • 11. Idiopathic portal hypertension in a renal transplant patient after long-term azathioprine therapy.
    Lorenz R; Brauer M; Classen M; Tornieporth N; Becker K
    Clin Investig; 1992 Feb; 70(2):152-5. PubMed ID: 1600341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic dysfunction in recipients of renal allografts.
    Berne TV; Chatterjee SN; Craig JR; Payne JE
    Surg Gynecol Obstet; 1975 Aug; 141(2):171-5. PubMed ID: 168654
    [No Abstract]   [Full Text] [Related]  

  • 13. Irreversible liver damage after azathioprine.
    Zarday Z; Veith FJ; Gliedman ML; Soberman R
    JAMA; 1972 Nov; 222(6):690-1. PubMed ID: 4562099
    [No Abstract]   [Full Text] [Related]  

  • 14. Jaundice after renal allotransplantation.
    Mozes MF; Ascher NL; Balfour HH; Simmons RL; Najarian JS
    Ann Surg; 1978 Dec; 188(6):783-90. PubMed ID: 216323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical course of 53 patients with venocclusive disease of the liver after marrow transplantation.
    McDonald GB; Sharma P; Matthews DE; Shulman HM; Thomas ED
    Transplantation; 1985 Jun; 39(6):603-8. PubMed ID: 3890288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azathioprine-induced hepatic veno-occlusive disease in a renal transplant recipient: histological regression following azathioprine withdrawal.
    Kohli HS; Jain D; Sud K; Jha V; Gupta KL; Sakhuja V; Joshi K
    Nephrol Dial Transplant; 1996 Aug; 11(8):1671-2. PubMed ID: 8856241
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of endothelial cell injury in the spectrum of azathioprine-induced liver disease after renal transplant: light microscopy and ultrastructural observations.
    Haboubi NY; Ali HH; Whitwell HL; Ackrill P
    Am J Gastroenterol; 1988 Mar; 83(3):256-61. PubMed ID: 3278593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of idiopathic portal hypertension after renal transplantation.
    Yanagisawa N; Sugaya H; Yunomura K; Harada T; Hisauchi T
    Gastroenterol Jpn; 1990 Oct; 25(5):643-8. PubMed ID: 2227256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and histologic features of Azathioprine-induced hepatotoxicity.
    Siramolpiwat S; Sakonlaya D
    Scand J Gastroenterol; 2017 Aug; 52(8):876-880. PubMed ID: 28388864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azathioprine hepatitis in kidney transplant recipients. A predisposing role of chronic viral hepatitis.
    Pol S; Cavalcanti R; Carnot F; Legendre C; Driss F; Chaix ML; Thervet E; Chkoff N; Brechot C; Berthelot P; Kreis H
    Transplantation; 1996 Jun; 61(12):1774-6. PubMed ID: 8685959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.